Sanjay Khanna
About Sanjay Khanna
Data last updated:
Sanjay Khanna is a Director at Ravenbhel Pharmaceuticals Private Limited (since 2000). The company operates in Pharma. Ravenbhel Pharmaceuticals Private Limited reported revenue of ₹25.73 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ravenbhel Pharmaceuticals Private Limited U24232PB2000PTC024120 | Director | 12 Dec 2000 | 2000 | ₹25.73 Cr (FY 2024) | Active |
Board colleagues of Sanjay Khanna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naresh Mahajan | 01411684 | Ravenbhel Pharmaceuticals Private Limited | Director |
| Sahil Mahajan | 00158373 | Ravenbhel Pharmaceuticals Private Limited | Director |
| Sanjeev Kumar Sharma | 00158299 | Ravenbhel Pharmaceuticals Private Limited | Director |
| Yogesh Khanna | 00158367 | Ravenbhel Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Khanna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Khanna
Sanjay Khanna currently holds 1 directorship: Ravenbhel Pharmaceuticals Private Limited (Director, since 12 Dec 2000, revenue ₹25.73 Cr (FY 2024)).
Sanjay Khanna was first appointed on 12 Dec 2000 as Director at Ravenbhel Pharmaceuticals Private Limited.
The current boards of Sanjay Khanna's companies include Naresh Mahajan (Ravenbhel Pharmaceuticals Private Limited), Sahil Mahajan (Ravenbhel Pharmaceuticals Private Limited), Sanjeev Kumar Sharma (Ravenbhel Pharmaceuticals Private Limited), Yogesh Khanna (Ravenbhel Pharmaceuticals Private Limited).